Skip to main content
Earnings Labs
Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ·Healthcare·Biotechnology

$10.66

+1.62%

Mkt Cap $909.44M

Analyst Ratings

Buy

9

Hold

0

Sell

0

Price Target (13 analysts)

$24.83

Range $19.00 – $28.00

Implied Upside

+132.9%

Consensus $24.83 vs current $10.66